Tobacco cessation pharmacotherapy use among racial/ethnic minorities in the United States:Considerations for primary care  

作　　者：Monica Webb Hooper Michael Payne Kimberly A.Parkinson 

机构地区：[1]Case Comprehensive Cancer Center,Case Western Reserve University,Cleveland,OH,USA

出　　处：《Family Medicine and Community Health》2017年第3期193-203,共11页家庭医学与社区卫生（英文）

摘　　要：Pharmacotherapies for tobacco cessation are efficacious and recommended during quit attempts.Racial/ethnic minorities in the United States are less likely to use medication-based aids for tobacco cessation,despite greater difficulty achieving long-term abstinence.The reasons for this include,among others,provider-and patient-level considerations.Primary care clinicians play an important role in encouraging racial/ethnic minority tobacco users to use cessation pharmacotherapy.To better understand pharmacotherapy use,we conducted a narrative review of patient-lev-el factors that may determine uptake and adherence.This review indicates that social and cultural factors impact pharmacotherapy use,including health care experiences,beliefs,perceptions,and norms.The proportion of individuals using pharmacotherapy during quit attempts and adhering to the full course of treatment may be enhanced with greater attention to the ethnocultural concerns of these groups.Culturally appropriate assessment and brief advice delivered by primary care providers could yield significant benefits in population health.Recommendations for treating racial/ethnic tobacco users with pharmacotherapy for cessation are offered.

关 键 词：Tobacco cessation PHARMACOTHERAPY racial/ethnic minorities primary care physician advice nicotine replacement therapy VARENICLINE bupropion 

分 类 号：S57[农业科学—作物学]